Verdence Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.82M | Buy |
4,481
+248
| +6% | +$101K | 0.12% | 174 |
|
2025
Q1 | $2.11M | Buy |
4,233
+456
| +12% | +$227K | 0.16% | 140 |
|
2024
Q4 | $1.96M | Sell |
3,777
-270
| -7% | -$140K | 0.16% | 157 |
|
2024
Q3 | $2.5M | Buy |
4,047
+174
| +4% | +$108K | 0.2% | 134 |
|
2024
Q2 | $2.14M | Buy |
3,873
+2
| +0.1% | +$1.11K | 0.19% | 139 |
|
2024
Q1 | $2.25M | Buy |
3,871
+3
| +0.1% | +$1.74K | 0.2% | 132 |
|
2023
Q4 | $2.05M | Buy |
3,868
+58
| +2% | +$30.8K | 0.2% | 128 |
|
2023
Q3 | $1.93M | Buy |
3,810
+267
| +8% | +$135K | 0.21% | 131 |
|
2023
Q2 | $1.85M | Sell |
3,543
-120
| -3% | -$62.6K | 0.21% | 120 |
|
2023
Q1 | $2.11M | Buy |
3,663
+959
| +35% | +$553K | 0.26% | 106 |
|
2022
Q4 | $1.49M | Buy |
2,704
+888
| +49% | +$489K | 0.18% | 130 |
|
2022
Q3 | $921K | Buy |
1,816
+106
| +6% | +$53.8K | 0.13% | 179 |
|
2022
Q2 | $929K | Buy |
1,710
+67
| +4% | +$36.4K | 0.12% | 186 |
|
2022
Q1 | $971K | Buy |
1,643
+50
| +3% | +$29.6K | 0.11% | 200 |
|
2021
Q4 | $1.06M | Buy |
1,593
+67
| +4% | +$44.7K | 0.13% | 171 |
|
2021
Q3 | $872K | Buy |
1,526
+615
| +68% | +$351K | 0.11% | 191 |
|
2021
Q2 | $460K | Sell |
911
-67
| -7% | -$33.8K | 0.06% | 265 |
|
2021
Q1 | $446K | Sell |
978
-45
| -4% | -$20.5K | 0.08% | 249 |
|
2020
Q4 | $477K | Sell |
1,023
-26
| -2% | -$12.1K | 0.09% | 215 |
|
2020
Q3 | $463K | Sell |
1,049
-2
| -0.2% | -$883 | 0.11% | 200 |
|
2020
Q2 | $381K | Buy |
1,051
+39
| +4% | +$14.1K | 0.09% | 211 |
|
2020
Q1 | $287K | Sell |
1,012
-122
| -11% | -$34.6K | 0.09% | 214 |
|
2019
Q4 | $369K | Buy |
1,134
+44
| +4% | +$14.3K | 0.09% | 210 |
|
2019
Q3 | $318K | Hold |
1,090
| – | – | 0.09% | 223 |
|
2019
Q2 | $320K | Buy |
1,090
+44
| +4% | +$12.9K | 0.09% | 215 |
|
2019
Q1 | $286K | Buy |
+1,046
| New | +$286K | 0.08% | 210 |
|